Clinical trials
Uterine Cervical Neoplasms trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Active, not recruiting | 10 |
| Unknown status | 7 |
| Recruiting | 5 |
| Terminated | 4 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universiteit Antwerpen | 7 |
| Merck Sharp & Dohme LLC | 4 |
| GlaxoSmithKline | 3 |
| Seagen Inc. | 3 |
| Seagen, a wholly owned subsidiary of Pfizer | 3 |
| Universitaire Ziekenhuizen KU Leuven | 3 |
| University Hospital, Ghent | 3 |
| Belgian Gynaecological Oncology Group | 2 |
| Daiichi Sankyo | 2 |
| Eli Lilly and Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 62 |
| Endometrial Neoplasms | 17 |
| Ovarian Neoplasms | 13 |
| Squamous Cell Carcinoma of Head and Neck | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Neoplasm Metastasis | 7 |
| Uterine Cervical Dysplasia | 7 |
| Recurrence | 6 |
| Carcinoma, Transitional Cell | 5 |
| Colorectal Neoplasms | 5 |
Trials
Showing 26 to 50 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.